NICA BTA Stock Overview
Nanologica AB (publ), a nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science applications worldwide.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Nanologica AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | kr5.95 |
52 Week High | kr7.00 |
52 Week Low | kr3.80 |
Beta | 0.64 |
1 Month Change | n/a |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 56.58% |
Recent News & Updates
Recent updates
Shareholder Returns
NICA BTA | SE Biotechs | SE Market | |
---|---|---|---|
7D | -8.5% | -0.9% | -1.2% |
1Y | n/a | -5.8% | 8.3% |
Return vs Industry: Insufficient data to determine how NICA BTA performed against the Swedish Biotechs industry.
Return vs Market: Insufficient data to determine how NICA BTA performed against the Swedish Market.
Price Volatility
NICA BTA volatility | |
---|---|
NICA BTA Average Weekly Movement | n/a |
Biotechs Industry Average Movement | 9.8% |
Market Average Movement | 6.1% |
10% most volatile stocks in SE Market | 12.8% |
10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: NICA BTA's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine NICA BTA's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2004 | 16 | Andreas Bhagwani | www.nanologica.com |
Nanologica AB (publ), a nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science applications worldwide. The company operates through two segments, Drug Development and Chromatography. It offers NLAB Saga, a new generation silica for preparative chromatography; and SVEA (U)HPLC analytical columns.
Nanologica AB (publ) Fundamentals Summary
NICA BTA fundamental statistics | |
---|---|
Market cap | kr282.74m |
Earnings (TTM) | -kr75.16m |
Revenue (TTM) | kr4.67m |
60.5x
P/S Ratio-3.8x
P/E RatioIs NICA BTA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
NICA BTA income statement (TTM) | |
---|---|
Revenue | kr4.67m |
Cost of Revenue | kr4.75m |
Gross Profit | -kr76.00k |
Other Expenses | kr75.08m |
Earnings | -kr75.16m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 26, 2024
Earnings per share (EPS) | -1.70 |
Gross Margin | -1.63% |
Net Profit Margin | -1,608.67% |
Debt/Equity Ratio | -3,517.2% |
How did NICA BTA perform over the long term?
See historical performance and comparison